Devon Medical Products has announced it has received FDA 510(k) clearance for its extriCARE 2400 Negative Pressure Wound Therapy system, according to a news release.
The extriCARE 2400 pump device provides negative pressure (suction) and is used with anatomically fitted bandages that create tight seals around various areas of the body. It is intended for the management of chronic, acute, traumatic, subacute and dehisced wounds, partial-thickness burns, diabetic and pressure ulcers, flaps and grafts.
"We designed and built the extriCARE NPWT system with patients and caregivers in mind after discussions with expert wound care nurses, physicians, and wound management thought leaders," says Dr. John A. Bennett, president of Devon Medical Products, in the release. "Ease of application, portability, and bandages creating airtight seals were deemed the most vital features necessary for safe and effective wound closure. The extriCARE encompasses these traits, and we're excited to offer this innovation in negative pressure wound therapy to healthcare professionals and patients."
Devon Medical Products is based in King of Prussia, Pa.
Related Articles on FDA Clearances:
Spacelabs Healthcare Receives FDA 510(k) Clearance for qube Patient Monitor
Intronix Technologies' EMG-Guided Injection System Receives FDA 510(k) Clearance
Cytori Therapeutics Receives FDA Clearance for New Version of Puregraft System